In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Cycloset (bromocriptine mesylate), quick-release bromocriptine (bromocriptine-QR), was approved for the treatment of type 2 diabetes, either as an adjunctive therapy or as monotherapy, in 2009.
Please login to view the rest of this drug profile.